Found 69 matching trials
Bioavailability and Bioequivalence of Ezetimibe Tablets in Healthy Subjects PHASE1 This study was conducted to assess the bioequivalence of the ezetimibe tabl...
Show More Location
Clinical Research Center
Learn More & Join Trial
Ezetimibe (SCH 58235) Taken With Either Atorvastatin or Simvastatin in Participants With Familial Hypercholesterolemia (MK-0653-018) PHASE3 The primary objective of this study is to evaluate the efficacy and the saf...
Show More Location
Multiple Locations
Learn More & Join Trial
Goal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin Intolerant Subjects -2 PHASE3 The primary objective was to evaluate the effect of 12 weeks of subcutaneou...
Show More Learn More & Join Trial
Bioequivalence of Ezetimibe Tablets in Healthy Subjects PHASE1 According to the relevant provisions of bioequivalence test, ezetimibe Tabl...
Show More Location
Phase Ⅰ Clinical Research Center
Learn More & Join Trial
Cholesterol Lowering Via Bempedoic Acid/Ezetimibe, an ACL-Inhibiting Regimen in Acute Coronary Syndrome Study PHASE4 The overall objective of the Cholesterol Lowering via Bempedoic Acid/Ezetim...
Show More Location
Kaiser Permanente Northern California Division of Research
Learn More & Join Trial
A Clinical Trial to Assess the Long Term Safety and Tolerability of MK-0653H in Japanese Participants With Hypercholesterolemia (MK-0653H-833) PHASE3 The study will assess the safety and tolerability of Ezetimibe 10 mg+ Rosuv...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study to Evaluate the Effectiveness of Ezetimibe/Atorvastatin 10 mg/20 mg Combination Tablet Compared to Marketed Ezetimibe 10 mg and Atorvastatin 20 mg Tablets in Participants With High Cholesterol (MK-0653C-185 AM1) PHASE3 The purpose of this study is to determine whether ezetimibe/atorvastatin 10...
Show More Location
Multiple Locations
Learn More & Join Trial
MD Ezetimibe Cyclosporine Interaction (0653-057) PHASE1 Study to determine the effect of multiple oral doses of ezetimibe on the ph...
Show More Location
Multiple Locations
Learn More & Join Trial
Treatment of HDL to Reduce the Incidence of Vascular Events HPS2-THRIVE PHASE3 The primary aim is to assess the effects of raising HDL cholesterol (the go...
Show More Location
Clinical Trial Service Unit, University of Oxford
Learn More & Join Trial
Goal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin Intolerant Subjects-4 PHASE3 The primary objective of the study was to evaluate the effect of 12 weeks o...
Show More Learn More & Join Trial